3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Leukemia
3
Thalassemia
2
Primary Immunodeficiency Diseases
2
Multiple Myeloma
2
Hemoglobinopathies
2
Hematologic Neoplasms
2
Fanconi Anemia
2
Cytopenia
2
Anemia, Sickle Cell
2
Anemia, Diamond-Blackfan
2
Anemia, Aplastic
2
Anemia
2
Uveal Melanoma
1
Recurrence
1
Osteopetrosis
1
Neoplasms, Plasma Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Interventions
Taxes
2
Sunitinib
2
Paclitaxel
2
N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide
2
Carboplatin
2
vorolanib
1
selinexor
1
saracatinib
1
pembrolizumab
1
epacadostat
1
belinostat
1
amrubicin
1
Thymectomy
1
Robotic Surgical Procedures
1
Ramucirumab
1
Prednisone
1
Prednisolone
1
Pemetrexed
1
Nivolumab
1
NVP-BKM120
1
MK 2206
1
Lapatinib
1
Fentanyl
1
Erlotinib Hydrochloride
1
Doxepin
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thymoma
×
AP 1903 reagent
×
Clear all
No trials found.